Life Biosciences

The AI engine Fit Assessment

Beta

Life Biosciences develops innovative drug therapies aimed at addressing age-related diseases and promoting healthier aging. Their research focuses on targeting biological mechanisms that contribute to the aging process.

Blurb

Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.

HQ Location

United States

Founded

2017

Employees

23

Total funding raised

$206.77M

Last Funding Event

Series C, $82.00M, January 5, 2022

Smart insights

  • Mehmood Khan (Chief Executive Officer) has 5 years of experience in the Life Sciences industry at Takeda
  • Mehmood Khan (Chief Executive Officer) has 13 years of experience in the Biotechnology industry at companies such as Takeda, Mayo Clinic and HemoShear Therapeutics
  • 6m headcount growth: -4%
  • 1Y headcount growth: 4%
  • Headcount-to-last-round ratio: 0.5 employees/$M

Developer of drug therapies intended to improve the lives of people as they age. The company's drugs help to combat the eight pathways of age-related decline and its work addresses health decline due to aging as a systemic breakdown of the body, rather than a series of isolated events and conditions, enabling senior citizens to tackle age-related diseases to extend healthy life spans.